Skip to content
LexBuild

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prolonged Storage of Red Blood Cells 

---
identifier: "/us/fr/00-10638"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prolonged Storage of Red Blood Cells"
title_number: 0
title_name: "Federal Register"
section_number: "00-10638"
section_name: "Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prolonged Storage of Red Blood Cells"
positive_law: false
currency: "2000-04-28"
last_updated: "2000-04-28"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Defense Department"
document_number: "00-10638"
document_type: "notice"
publication_date: "2000-04-28"
agencies:
  - "Defense Department"
  - "Army Department"
fr_citation: "65 FR 24943"
fr_volume: 65
fr_action: "Notice."
---

#  Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Prolonged Storage of Red Blood Cells

**AGENCY:**

U.S. Army Medical Research and Materiel Command, Department of the Army, DoD.

**ACTION:**

Notice.

**SUMMARY:**

In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application Serial No. 09/154,102 entitled “Prolonged Storage of Red Blood Cells”, filed 16 September 1998. This patent has been assigned to the United States Government as represented by the Secretary of the Army.

**ADDRESSES:**

Commander, U.S. Army Medical Research and Material Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

**FOR FURTHER INFORMATION CONTACT:**

Mr. Jay P. Winchester, Attorney-Advisor, (301) 619-2065 or telefax (301) 619-5034.

**SUPPLEMENTARY INFORMATION:**

The invention discloses novel additive solutions useful for the storage of human red blood cells (RBCs) under refrigerated conditions. Also disclosed is a method of using the additive solutions in an appropriate volume to preserve RBCs at about 1° to 6° for up to 10 weeks. Additive solutions and processes in accordance with this invention allow the viable storage of human RBCs for an extended period of time in a solution which is directly infusible into humans.

Gregory D. Showalter,

Army Federal Register Liaison Officer.